Board of Directors
William P. Wiesmann M.D., Chairman of the Board, Co-Founder
Dr. Wiesmann, co-founder of HemCon, served as the Director for Combat Casualty Care at the U.S. Army Medical Research and Material Command Post, at Ft. Detrick in Frederick, Maryland until he retired from the Army as a Colonel in 1997. Throughout his military career, Dr. Wiesmann led the design and development teams that produced novel technologies for improved battlefield survival, including the LSTAT (Life Support for Trauma and Transport) life support system, the ASSTC (Advanced Surgical Suite for Trauma Casualties) field support hospital, the Micro-infusion pump, and body worn sensor suits.

Dr. Wiesmann received his undergraduate degree in chemistry from the University of Cincinnati and his medical degree from Washington University in St. Louis, Missouri. He completed advanced research training as a fellow at the National Heart, Blood and Lung Institute at the National Institutes of Health. Dr. Wiesmann served as a senior scientist at the Walter Reed Institute of Research and as an attending nephrologist at Walter Reed Hospital.

Dr. Wiesmann has been published in over 70 scientific publications, authored several book chapters and has 15 patents awarded and pending. He currently serves on the Board of Trustees at Harvey Mudd College in Claremont, California, is the Chairman of the Scientific Advisory Board of the National Tissue Engineering Center (NTEC) and a member of the University of Southern California (USC) Engineering School Board of Councilors.

John W. Morgan, President, CEO, Board Member
John W. Morgan is President and Chief Executive Officer and has been with HemCon since May 2004. Morgan has more than 21 years of general management experience with four multi-national healthcare manufacturing and distribution organizations. He launched his career at Baxter International. Over his 14 year tenure at Baxter, he worked his way up the ranks from sales representative to President of the Mid America Region where he led a $500 million regional company that covered 12 states and several regional offices.

Following Baxter, Mr. Morgan served as President-Americas for Regent Medical Products, a U.S. subsidiary of the London International Group, a manufacturer and marketer of a variety of specialty surgical and medical gloves. His responsibilities spanned across North, South and Latin America.

Mr. Morgan then served as President and Chief Executive Officer of Epitope Inc., an Oregon-based medical device and diagnostic firm that develops oral fluid technologies to provide non-invasive testing for infectious diseases and drugs of abuse. He increased revenue 21% in the first fiscal year and moved the company from a cash burn rate of $1 million per month to breakeven in four fiscal quarters. The market capitalization of the company grew from $50 million to more than $300 million during Mr. Morgan's tenure.

From 1999 to 2002, Morgan served as President and Chief Executive Officer at Curon Medical Inc., a medical device manufacturing firm specializing in the treatment of gastrointestinal diseases. During his tenure at Curon, Morgan raised $60 million in working capital and increased market capitalization by $250 million through an initial public offering, and oversaw clinical trials and Food and Drug Administration submissions for two medical devices for gastroenterology and general surgery applications.

A native of Chicago, Illinois, Morgan graduated from The University of Arizona with a B.S. in Public Administration and Economics. He is a member of the Young Presidents Organization and Northern California Skeletal Dysplasia Clinic. John also serves on the boards of SMART (Start Making a Reader Today),Oregon's leading literacy program for young people and The Oregon Innovation Council, which is dedicated to increasing Oregon's competitiveness in a global economy and promoting commercialization of university-based research.

Kenton Gregory M.D., Board Member
Dr. Kenton Gregory, co-founder of HemCon, is an associate professor of biomedical engineering at the Oregon Graduate Institute of Science and Technology and an assistant professor of medicine at Oregon Health and Science University. He also holds an endowed chair in laser medicine and surgery at the Providence St. Vincent Medical Center and serves as director at the Oregon Medical Laser Center (OMLC), which collaborates nationally in investigating such fields as hemorrhage control, laser thrombolysis for stroke, and elastin biomaterials for the repair and replacement of tissues.

Gregory received his undergraduate degree in engineering and Doctor of Medicine from the University of Southern California. He completed his internship, residency in Internal Medicine and a fellowship in Cardiology at the Wadsworth Veterans Administration Hospital in Los Angeles, California, and an additional research fellowship in Cardiology at the Irvine Medical Center in Orange, CA. He has held teaching positions at the University of California, Irvine Medical School, Harvard University School of Medicine and served as staff cardiologist at Massachusetts General Hospital.

Gregory has been awarded 19 domestic patents, 3 international patents, has authored and/or co-authored 11 original reports, 4 book chapters, 36 manuscripts, and 80 abstracts. He has been Principal Investigator on 5 FDA sponsored clinical trials and received over $25 million in grants to research novel techniques for the repair and replacement of tissues. He is a member of numerous medical societies including the American Medical Society, American Heart Association, Society for Biomaterials and the American College of Cardiology, and he chairs a Cardiovascular Section at The International Society for Optical Engineering.

Andrew Miller, CEO, Stimson Lumber, Board Member
Andrew W. Miller, 46 , President/CEO Stimson Lumber Company, Portland, OR. Stimson is an integrated timberland and wood products manufacturing company with operations in OR, WA, ID, and MT. Graduate from Grinnell College with BA in Economics. Earned an MBA in Finance from Columbia University. Since college have been employed in the Forest Products Industry with Plum Creek and Weyerhaeuser, prior to joining Stimson in 1991. Serves on multiple regional and national industry association Boards, and several non-profit Boards in the Portland area. Four children ages 12-18. Primary hobbies are outdoor sports and competitive running.

Richard M. Berkeley , Board Member
Richard is a Partner and joined Camden Partners in 2002. Prior to joining Camden, he spent 19 years with Alex. Brown & Sons, Incorporated and its successor organizations, Bankers Trust Corporation and Deutsche Bank Securities, Inc. Richard focuses on investments in the business and financial services, health care and education markets for the firm.

Previously, Richard was Managing Director and Global Head of the Equity Private Placements Group at Deutsche Bank Securities, Inc., where he was responsible for the origination, structuring, and consummation of private equity financings for private and public companies. During his tenure, Richard and his team members completed more than 135 private equity financings for private and public companies. He has served, or is currently serving, on the Boards of Directors of a number of private companies - including Barton-Cotton, Inc., WageWorks, Inc., and RealPage, Inc. - educational institutions, and charitable organizations. He also served as an officer in the United States Air Force between 1974 and 1976. Richard is a former member of the Board of Managers of the University of Virginia Alumni Association, and he is former President and a current member of the Board of Directors of the Jefferson Scholars Foundation at the University of Virginia.

Richard earned his B.A., J.D., and M.B.A. degrees from the University of Virginia.